11-4-8　ⓔ文献

  1. WHO/IARC GLOBOCAN 2020, Cancer Today, Data visualization tools for exploring the global cancer burden in 2020. https://gco.iarc.fr/today/data/factsheets/cancers/39-All-cancers-fact-sheet.pdf

  2. Herrero R, Park JY, et al: The fight against gastric cancer–the IARC Working Group report. Best Pract Res Clin Gastroenterol, 2014; 28: 1107–1114.

  3. がん研究振興財団：がんの統計’21. 国立がん研究センター癌情報サービス．https://ganjoho.jp/reg_stat/statistics/brochure/backnumber/2021_jp.html

  4. Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet, 1983; i: 1273–1275.

  5. Kodama M, Murakami K, et al: Ten-year prospective follow–up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication. J Gastroenterol, 2012; 47: 394–403.

  6. Kong YJ, Yi HG, et al: Histological changes of gastric mucosa after Helicobacter pylori eradication: a systematic review and meta–analysis. World J Gastroenterol, 2014; 20; 5903–5911.

  7. Hwang YJ, Kim N, et al: Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication: a prospective study for up to 10 years. Aliment Pharmacol Ther, 2018; 47: 380–390.

  8. Choi IJ, Kook MC, et al: Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med, 2018; 378: 1085–1095.

  9. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process–first American cancer society award lecture on cancer epidemiology and prevention. Cancer Res, 1992; 52: 6735–6740.

  10. Uemura N, Okamoto S, et al: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med, 2001; 345: 784–778.

  11. Higashi H, Tsutsumi R, et al: SHP–2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science, 2002; 295: 683–686.

  12. Azuma T, Yamazaki S, et al: Association between diversity in the Src homology 2 domain–containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J Infect Dis, 2004; 189: 820–877.

  13. Tsugane S, Sasazuki S, et al: Salt and salted food intake and subsequent risk of gastric cancer among middle–aged Japanese men and women. Br J Cancer, 2004; 90: 128–134.

  14. Shinozaki–Ushiku A, et al: Update on Epstein–Barr virus and gastric cancer. Int J Oncol, 2015; 46: 1421–1434.

  15. Brierley JD, Gospodarowicz MK, et al eds: 8th edition of the UICC TNM classification of Malignant Tumors, JOHN WILEY & SONS, 2017.

  16. 日本胃癌学会編：胃癌取扱い規約 第15版，金原出版，2017.

  17. Ito M, Tanaka S, et al: Morphological changes in human gastric tumours after eradication therapy of Helicobacter pylori in a short–term follow-up. Aliment Pharmacol Ther, 2005; 21: 559–566.

  18. Yamamoto K, Kato M, et al: Clinicopathological analysis of early–stage gastric cancers detected after successful eradication of Helicobacter pylori. Helicobacter, 2011; 16: 210–216.

  19. Kobayashi M, Hashimoto S, et al: Magnifying narrow–band imaging of surface maturation in early differentiated–type gastric cancers after Helicobacter pylori eradication. J Gastroenterol, 2013; 48: 1332–1342.

  20. Kodama M, Okimoto T, et al: Endoscopic and immunohistochemical characteristics of gastric cancer with versus without Helicobacter pylori eradication. Digestion, 2018; 97: 288–297.

  21. Masuda K, Urabe Y, et al: Genomic landscape of epithelium with low–grade atypia on gastric cancer after Helicobacter pylori eradiation therapy. J Gastroenterol, 2019; 54: 907–915.

  22. 八尾隆史，上山浩也，他:新しいタイプの胃癌－胃底腺型胃癌の臨床病理学的特徴と発育進展様式および悪性度．胃と腸，2010; 45: 1192–1202.

  23. Ueyama H, Yao T, et al: Gastric adenocarcinoma of fundic gland type (chief cell prrdominant type) : proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol, 2010; 34: 609–619.

  24. Horiuchi Y, Fujisaki J, et al: Biological behavior of the intramucosal Helicobacter pylori–negative undifferentiated–type early gastric cancer : comparison with Helicobacter pylori positive early gastric cancer. Gastric Cancer, 2016; 19: 160–165.

  25. Cancer Genome Atlas Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature, 2014; 513: 202–209.

  26. Bang YJ, Van Cutsem E, et al: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2–positive advanced gastric or gastro–oesophageal junction cancer (ToGA): a phase 3, open–label, randomised controlled trial. Lancet, 2010; 376: 687–697.

  27. 日本胃癌学会編：胃癌治療ガイドライン医師用 2021年7月改訂 第6版，金原出版，2021.

  28. Miki K: Gastric cancer screening by combined assay for serum anti–Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method". Proc Jpn Acad Ser B Phys Biol Sci, 2011; 87: 405–414.

  29. Asada K, Nakajima T, et al: Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study. Gut, 2015; 64: 388–396.

  30. Jun JK, Choi KS, et al: Effectiveness of the Korean National Cancer Screening Program in reducing gastric cancer mortality. Gastroenterology, 2017; 152: 1319–1328.

  31. Wong BC, Lam SK, et al: Helicobacter pylori eradication to prevent gastric cancer in a high–risk region of China: a randomized controlled trial. JAMA, 2004; 291: 187–194.

  32. Fukase K, Kato M, et al: Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet, 2008; 372: 392–397.

  33. Ford AC, Forman D, et al: Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta–analysis of randomised controlled trials. BMJ, 2014; 348: g3174.

  34. Yoon SB, Park JM, et al: Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis. Helicobacter, 2014; 19: 243–248.

  35. Lee YC, Chiang TH, et al: Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta–analysis. Gastroenterology, 2016; 150: 1113–1124.

  36. Sugano K: Effect of Helicobacter pylori eradication on the incidence of gastric cancer: a systematic review and meta–analysis. Gastric Cancer, 2019; 22: 435–445.

  37. 日本ヘリコバクター学会ガイドライン作成委員会編：H. pylori感染の診断と治療のガイドライン 2016改訂版，先端医学社，2016.